Skip to main content
Top
Published in: Current Atherosclerosis Reports 2/2011

01-04-2011

The Role of Anxiety and Emotional Stress as a Risk Factor in Treatment-Resistant Hypertension

Authors: Michael Greenage, Burak Kulaksizoglu, Mehmet Cilingiroglu, Rizwan Ali

Published in: Current Atherosclerosis Reports | Issue 2/2011

Login to get access

Abstract

Depression and anxiety are both known to be co-morbid with coronary heart disease. Given the high prevalence of coronary heart disease today, specifically the aspect of hypertension, it seems more important than ever to investigate whether or not treatment of these co-morbidities can have an effect on reducing hypertension. This article summarizes the limited amount of literature that has been published in this area and highlights what we believe to be a missing key element that will guide our own future research in this area.
Literature
1.
go back to reference White WB, Baker LH: Episodic Hypertension Secondary to Panic Disorder. Archives of Internal Medicine 1986, 146: 1129–1130.PubMedCrossRef White WB, Baker LH: Episodic Hypertension Secondary to Panic Disorder. Archives of Internal Medicine 1986, 146: 1129–1130.PubMedCrossRef
2.
go back to reference White WB, Baker LH: Ambulatory Blood Pressure Monitoring in Patients with Panic Disorder. Archives of Internal Medicine 1987, 147: 1973–1975.PubMedCrossRef White WB, Baker LH: Ambulatory Blood Pressure Monitoring in Patients with Panic Disorder. Archives of Internal Medicine 1987, 147: 1973–1975.PubMedCrossRef
3.
go back to reference Kessler RC, Chiu WT, et al., Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 June;62(6):617–27.PubMedCrossRef Kessler RC, Chiu WT, et al., Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 June;62(6):617–27.PubMedCrossRef
5.
go back to reference Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. American Journal of Psychiatry 1998, 155:4–111.PubMed Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. American Journal of Psychiatry 1998, 155:4–111.PubMed
6.
go back to reference Carretro OA, Oparil S, Essential Hypertension: Part I: Definition and Etiology. Circulation 2000, 3: 329–35. Carretro OA, Oparil S, Essential Hypertension: Part I: Definition and Etiology. Circulation 2000, 3: 329–35.
7.
go back to reference Davies SJ, Ghahramani P., et al.: Panic disorder, anxiety, and depression in treatment resistant hypertension – a case control study. Journal of Hypertension 1997, Oct;15(10): 1077-1082PubMedCrossRef Davies SJ, Ghahramani P., et al.: Panic disorder, anxiety, and depression in treatment resistant hypertension – a case control study. Journal of Hypertension 1997, Oct;15(10): 1077-1082PubMedCrossRef
8.
9.
go back to reference Janszky, I., Ahnve, S., et al: Early-Onset Depression, Anxiety, and Risk of Subsequent Coronary Heart Disease: 37-Year Follow-Up of 49,321 Young Swedish Men. Journal of the American College of Cardiology, 2010(56): 31–37. Janszky, I., Ahnve, S., et al: Early-Onset Depression, Anxiety, and Risk of Subsequent Coronary Heart Disease: 37-Year Follow-Up of 49,321 Young Swedish Men. Journal of the American College of Cardiology, 2010(56): 31–37.
10.
go back to reference • Roest AM, Martens EJ, et al: Anxiety and Risk of Incident Coronary Heart Disease: A Meta-Analysis. Journal of the American College of Cardiology, 2010(56)38. This study highlights the significant role of anxiety spectrum disorders and their impact on coronary artery disease. • Roest AM, Martens EJ, et al: Anxiety and Risk of Incident Coronary Heart Disease: A Meta-Analysis. Journal of the American College of Cardiology, 2010(56)38. This study highlights the significant role of anxiety spectrum disorders and their impact on coronary artery disease.
Metadata
Title
The Role of Anxiety and Emotional Stress as a Risk Factor in Treatment-Resistant Hypertension
Authors
Michael Greenage
Burak Kulaksizoglu
Mehmet Cilingiroglu
Rizwan Ali
Publication date
01-04-2011
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 2/2011
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-010-0154-z

Other articles of this Issue 2/2011

Current Atherosclerosis Reports 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.